Total Payments
$287,176
2024 Payments
$31,245
Companies
22
Transactions
338
Medicare Patients
789
Medicare Billing
$135,147
Payment Breakdown by Category
Consulting$194,491 (67.7%)
Other$59,073 (20.6%)
Travel$23,228 (8.1%)
Food & Beverage$10,213 (3.6%)
Education$172.13 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $194,491 | 73 | 67.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,673 | 14 | 19.7% |
| Travel and Lodging | $23,228 | 78 | 8.1% |
| Food and Beverage | $10,213 | 166 | 3.6% |
| Honoraria | $2,400 | 1 | 0.8% |
| Education | $172.13 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Seagen Inc. | $43,739 | 31 | $0 (2023) |
| Eisai Inc. | $43,092 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $40,146 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $37,946 | 40 | $0 (2024) |
| Genentech USA, Inc. | $33,960 | 31 | $0 (2019) |
| GlaxoSmithKline, LLC. | $21,070 | 20 | $0 (2024) |
| TESARO, Inc. | $16,374 | 44 | $0 (2019) |
| Medical Device Business Services, Inc. | $16,234 | 17 | $0 (2023) |
| Ethicon US, LLC | $7,298 | 27 | $0 (2024) |
| EMD Serono Research & Development Institute, Inc. | $6,025 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,245 | 32 | Eisai Inc. ($7,399) |
| 2023 | $10,643 | 28 | AstraZeneca Pharmaceuticals LP ($2,980) |
| 2022 | $44,304 | 46 | Seagen Inc. ($27,205) |
| 2021 | $39,957 | 30 | Seagen Inc. ($14,035) |
| 2020 | $27,671 | 27 | Eisai Inc. ($11,558) |
| 2019 | $51,658 | 80 | EISAI INC. ($16,453) |
| 2018 | $39,797 | 55 | Genentech USA, Inc. ($16,011) |
| 2017 | $41,902 | 40 | Genentech USA, Inc. ($17,635) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 12/06/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Consulting Fee | In-kind items and services | $4,000.00 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 11/03/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $79.22 | General |
| Category: Oncology | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.43 | General |
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Oncology | ||||||
| 10/19/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Virtual Incision Corporation | Mira (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Device | ||||||
| 09/27/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Oncology | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Education | In-kind items and services | $64.50 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $4,890.00 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Aadi Bioscience, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| 07/26/2024 | Aadi Bioscience, Inc. | — | Food and Beverage | In-kind items and services | $112.50 | General |
| 07/22/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 06/27/2024 | Virtual Incision Corporation | Mira (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Device | ||||||
| 06/02/2024 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $63.26 | General |
| Category: Cancer | ||||||
| 06/02/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Oncology | ||||||
| 06/01/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $78.61 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,445.00 | General |
| Category: Oncology | ||||||
| 04/03/2024 | Ethicon US, LLC | VISTASEAL (Biological) | Food and Beverage | In-kind items and services | $100.85 | General |
| Category: Biosurgical | ||||||
| 03/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $64.00 | General |
| Category: Oncology | ||||||
| 03/17/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Oncology | ||||||
| 03/15/2024 | Aadi Bioscience, Inc. | — | Food and Beverage | In-kind items and services | $99.98 | General |
| 02/22/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 187 | 382 | $102,350 | $41,343 |
| 2022 | 5 | 163 | 303 | $40,043 | $22,863 |
| 2021 | 5 | 189 | 378 | $46,008 | $28,189 |
| 2020 | 8 | 250 | 414 | $154,589 | $42,753 |
Total Patients
789
Total Services
1,477
Medicare Billing
$135,147
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 37 | 174 | $26,174 | $18,724 | 71.5% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 15 | 15 | $54,077 | $10,544 | 19.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 31 | 31 | $6,288 | $4,303 | 68.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 64 | 74 | $5,154 | $3,229 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 31 | $3,190 | $2,347 | 73.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 57 | $7,467 | $2,196 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 32 | 114 | $18,022 | $12,245 | 67.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 29 | 29 | $6,491 | $3,650 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 63 | 77 | $5,757 | $3,047 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 40 | $4,269 | $2,611 | 61.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 43 | $5,504 | $1,310 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 145 | $22,390 | $15,413 | 68.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 45 | 71 | $7,360 | $4,659 | 63.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 63 | 79 | $5,580 | $3,330 | 59.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 21 | 21 | $4,399 | $2,881 | 65.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 62 | $6,279 | $1,905 | 30.3% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 20 | 20 | $83,433 | $14,057 | 16.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 38 | 125 | $15,866 | $10,457 | 65.9% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2020 | 15 | 15 | $24,900 | $4,728 | 19.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 50 | 81 | $7,075 | $4,580 | 64.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 28 | 28 | $5,638 | $3,294 | 58.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 27 | 66 | $6,534 | $2,100 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 57 | 64 | $3,658 | $1,868 | 51.1% |
| 38900 | Lymph node imaging during surgery | Facility | 2020 | 15 | 15 | $7,485 | $1,668 | 22.3% |
About Dr. Robert Naumann, MD
Dr. Robert Naumann, MD is a Obstetrics & Gynecology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730196098.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Naumann, MD has received a total of $287,176 in payments from pharmaceutical and medical device companies, with $31,245 received in 2024. These payments were reported across 338 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($194,491).
As a Medicare-enrolled provider, Naumann has provided services to 789 Medicare beneficiaries, totaling 1,477 services with total Medicare billing of $135,147. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology
- Location Charlotte, NC
- Active Since 08/01/2006
- Last Updated 07/15/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1730196098
Products in Payments
- Lenvima (Drug) $43,092
- TIVDAK (Biological) $39,039
- LYNPARZA (Drug) $37,203
- Avastin (Biological) $33,960
- ZEJULA (Drug) $27,078
- Enseal X1 (Device) $8,614
- Rubraca (Drug) $4,436
- Epkinly (Drug) $4,026
- Mira (Device) $2,500
- KISQALI (Drug) $2,167
- HARMONIC Product Family (Device) $1,542
- KEYTRUDA (Biological) $1,339
- TIVDAK (Drug) $1,185
- OPDIVO (Biological) $575.00
- Fyarro (Drug) $202.20
- ENSEAL Product Family (Device) $179.16
- Enseal (Device) $163.66
- STRATAFIX (Device) $157.11
- Brachytherapy Source (Device) $129.56
- JEMPERLI (Biological) $127.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Charlotte
Jerry Matkins, Md, MD
Obstetrics & Gynecology — Payments: $411,912
Obstetrics & Gynecology $411,912
Leslie Hansen-Lindner, Md, MD
Obstetrics & Gynecology — Payments: $272,074
Obstetrics & Gynecology $272,074
Dr. Cary Fishburne, Md, MD
Obstetrics & Gynecology — Payments: $158,097
Obstetrics & Gynecology $158,097
Erin Crane, Md, MD
Obstetrics & Gynecology — Payments: $93,808
Obstetrics & Gynecology $93,808
Melissa Woolworth, Md, MD
Obstetrics & Gynecology — Payments: $93,102
Obstetrics & Gynecology $93,102
Jubilee Brown, Md, MD
Obstetrics & Gynecology — Payments: $89,081
Obstetrics & Gynecology $89,081